News

João Laudo de Camargo and Luiz Pompeu discuss the CVM’s ‘Regime Fácil’ in an article published in Valor Econômico

Share

In an article published in the “Palavra do Gestor” column of Valor Econômico, our partner João Laudo de Camargo and our lawyer Luiz Pompeu discuss the CVM’s “Fácil” Regime, which came into force on 16 March with CVM Resolution 232, which set out its rules.

The Regime for Facilitating Access to Capital and Incentives for Listings (Fácil) has the primary objective of enabling companies with annual gross revenue of less than R$ 500 million, known as smaller companies (CMPs), to access the capital markets more easily and at a lower cost, thanks to regulatory discounts.

According to the authors, having noted that in 2025 there was a reduction in the number of listed companies registered with B3, it is expected that, with Fácil, this trend will be reversed. The scheme, they argue, has the potential to be an attractive alternative for CMPs to raise funds through public offerings of securities – whether shares or debt instruments – with the creation of a secondary market that could allow partners to divest.“The measure is beneficial, in fact, for Private Equity Funds (FIPs), as their managers are tasked not only with identifying sound investment opportunities, but also, subsequently, with reselling the equity stakes acquired by the FIP, which are temporary in nature,” explain João Laudo and Luiz Matheus.

Read the full article on the Valor website.

Authors

news

You may also be interested in

Mauricio Jayme e Silva is a...

Our partner Mauricio Jayme e Silva joined the Capital Markets Committee of the São Paulo Bar Association (OAB SP) at the end of July. The Committee promotes the study and discussion of strategic issues aimed at strengthening and modernising the capital markets in Brazil. Congratulations, Mauricio! We wish…

Bernardo da Costa e Silva takes...

Our partner Bernardo da Costa e Silva spoke to *Valor Econômico* in a report covering yesterday’s (25 August) decision by the Board of the Brazilian Securities and Exchange Commission (CVM) in favour of the takeover bid for Oncoclínicas, valued at around R$ 6.5 billion. The newspaper reported that…